Cargando…

Comparison of subtyping methods for neuroimaging studies in Alzheimer’s disease: a call for harmonization

Biological subtypes in Alzheimer’s disease, originally identified on neuropathological data, have been translated to in vivo biomarkers such as structural magnetic resonance imaging and positron emission tomography, to disentangle the heterogeneity within Alzheimer’s disease. Although there is metho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohanty, Rosaleena, Mårtensson, Gustav, Poulakis, Konstantinos, Muehlboeck, J-Sebastian, Rodriguez-Vieitez, Elena, Chiotis, Konstantinos, Grothe, Michel J, Nordberg, Agneta, Ferreira, Daniel, Westman, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713995/ https://www.ncbi.nlm.nih.gov/pubmed/33305264 http://dx.doi.org/10.1093/braincomms/fcaa192

Ejemplares similares

Assessment of Tau Pathology as Measured by (18)F-THK5317 and (18)F-Flortaucipir PET and Their Relation to Brain Atrophy and Cognition in Alzheimer’s Disease
por: Colato, Elisa, et al.
Publicado: (2021)

Neuropathologic Features of Antemortem Atrophy-Based Subtypes of Alzheimer Disease
por: Mohanty, Rosaleena, et al.
Publicado: (2022)

The hippocampal sparing subtype of Alzheimer’s disease assessed in neuropathology and in vivo tau positron emission tomography: a systematic review
por: Ferreira, Daniel, et al.
Publicado: (2022)

Associations between different tau-PET patterns and longitudinal atrophy in the Alzheimer’s disease continuum: biological and methodological perspectives from disease heterogeneity
por: Mohanty, Rosaleena, et al.
Publicado: (2023)

Correction: Associations between different tau‑PET patterns and longitudinal atrophy in the Alzheimer’s disease continuum: biological and methodological perspectives from disease heterogeneity
por: Mohanty, Rosaleena, et al.
Publicado: (2023)

Longitudinal association between astrocyte function and glucose metabolism in autosomal dominant Alzheimer’s disease
por: Carter, Stephen F., et al.
Publicado: (2018)

[(18)F]THK5317 imaging as a tool for predicting prospective cognitive decline in Alzheimer’s disease
por: Chiotis, Konstantinos, et al.
Publicado: (2020)

Multi-cohort and longitudinal Bayesian clustering study of stage and subtype in Alzheimer’s disease
por: Poulakis, Konstantinos, et al.
Publicado: (2022)

Clustering and disease subtyping in Neuroscience, toward better methodological adaptations
por: Poulakis, Konstantinos, et al.
Publicado: (2023)

Alzheimer’s disease profiled by fluid and imaging markers: tau PET best predicts cognitive decline
por: Bucci, Marco, et al.
Publicado: (2021)

Tau positron emission tomography imaging in tauopathies: The added hurdle of off-target binding
por: Lemoine, Laetitia, et al.
Publicado: (2018)

Differential response to donepezil in MRI subtypes of mild cognitive impairment
por: Diaz-Galvan, Patricia, et al.
Publicado: (2023)

Biological subtypes of Alzheimer disease: A systematic review and meta-analysis
por: Ferreira, Daniel, et al.
Publicado: (2020)

Tracking reactive astrogliosis in autosomal dominant and sporadic Alzheimer’s disease with multi-modal PET and plasma GFAP
por: Chiotis, Konstantinos, et al.
Publicado: (2023)

Correction: Differential response to donepezil in MRI subtypes of mild cognitive impairment
por: Diaz‑Galvan, Patricia, et al.
Publicado: (2023)

Cross-interaction of tau PET tracers with monoamine oxidase B: evidence from in silico modelling and in vivo imaging
por: Murugan, N. Arul, et al.
Publicado: (2019)

Tau PET imaging: present and future directions
por: Saint-Aubert, Laure, et al.
Publicado: (2017)

Tau PET imaging in neurodegenerative tauopathies—still a challenge
por: Leuzy, Antoine, et al.
Publicado: (2019)

Functional Connectivity and Compensation of Phonemic Fluency in Aging
por: Mohanty, Rosaleena, et al.
Publicado: (2021)

Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer’s disease
por: Rodriguez-Vieitez, Elena, et al.
Publicado: (2016)

Regional tau deposition measured by [(18)F]THK5317 positron emission tomography is associated to cognition via glucose metabolism in Alzheimer’s disease
por: Saint-Aubert, Laure, et al.
Publicado: (2016)

Dual tracer tau PET imaging reveals different molecular targets for (11)C-THK5351 and (11)C-PBB3 in the Alzheimer brain
por: Chiotis, Konstantinos, et al.
Publicado: (2018)

AVRA: Automatic visual ratings of atrophy from MRI images using recurrent convolutional neural networks
por: Mårtensson, Gustav, et al.
Publicado: (2019)

Regional Disconnection in Alzheimer Dementia and Amyloid-Positive Mild Cognitive Impairment: Association Between EEG Functional Connectivity and Brain Glucose Metabolism
por: Smailovic, Una, et al.
Publicado: (2020)

Cortical microstructural correlates of astrocytosis in autosomal-dominant Alzheimer disease
por: Vilaplana, Eduard, et al.
Publicado: (2020)

Amyloid PET in European and North American cohorts; and exploring age as a limit to clinical use of amyloid imaging
por: Chiotis, Konstantinos, et al.
Publicado: (2015)

Spatial Normalization of (18)F-Flutemetamol PET Images Using an Adaptive Principal-Component Template
por: Lilja, Johan, et al.
Publicado: (2019)

Data-driven FDG-PET subtypes of Alzheimer’s disease-related neurodegeneration
por: Levin, Fedor, et al.
Publicado: (2021)

Distinct subtypes of Alzheimer’s disease based on patterns of brain atrophy: longitudinal trajectories and clinical applications
por: Ferreira, Daniel, et al.
Publicado: (2017)

Clinical validity of increased cortical binding of tau ligands of the THK family and PBB3 on PET as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework
por: Chiotis, Konstantinos, et al.
Publicado: (2021)

Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease
por: Leuzy, Antoine, et al.
Publicado: (2019)

Fully bayesian longitudinal unsupervised learning for the assessment and visualization of AD heterogeneity and progression
por: Poulakis, Konstantinos, et al.
Publicado: (2020)

Regional Magnetic Resonance Imaging Measures for Multivariate Analysis in Alzheimer’s Disease and Mild Cognitive Impairment
por: Westman, Eric, et al.
Publicado: (2012)

Early astrocytosis in autosomal dominant Alzheimer’s disease measured in vivo by multi-tracer positron emission tomography
por: Schöll, Michael, et al.
Publicado: (2015)

Astrocyte Signature in Alzheimer’s Disease Continuum through a Multi-PET Tracer Imaging Perspective
por: Fontana, Igor C., et al.
Publicado: (2023)

Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigm
por: Chiotis, Konstantinos, et al.
Publicado: (2016)

MRI data-driven clustering reveals different subtypes of Dementia with Lewy bodies
por: Inguanzo, Anna, et al.
Publicado: (2023)

Optimal timing of tau pathology imaging and automatic extraction of a reference region using dynamic [(18)F]THK5317 PET
por: Jonasson, My, et al.
Publicado: (2019)

Clinical impact of [(18)F]flutemetamol PET among memory clinic patients with an unclear diagnosis
por: Leuzy, Antoine, et al.
Publicado: (2019)

Cortical Networks Underpinning Compensation of Verbal Fluency in Normal Aging
por: Gonzalez-Burgos, Lissett, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qp3kvi9kda14ibao8ee66astpu